9G2.SI SES
Singapore Institute of Advanced Medicine Holdings Ltd.
1W: +0.0%
1M: -6.7%
3M: -3.5%
YTD: -47.2%
1Y: -3.5%
S$0.03 ($0.02)
+0.00 (+0.00%)
Weekly Expected Move ±8.9%
S$0
S$0
S$0
S$0
S$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$11M
+25.5% ▲
Capital Expenditures
$148K
+72.3% ▲
4Y CAGR: -59.5%
Free Cash Flow
-$11M
+27.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$319K
+96.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$9M | -$14M | -$19M | -$37M | -$26M |
| Depreciation & Amort. | $5M | $5M | $6M | $12M | $12M |
| Stock-Based Comp. | $456K | $415K | $466K | -$65K | $57K |
| Change in Working Capital | $411K | $2M | $5M | -$4M | -$808K |
| Other Non-Cash Items | $9M | $9M | $9M | $15M | $4M |
| Operating Cash Flow | -$4M | -$7M | -$5M | -$14M | -$11M |
| — Investing Activities — | |||||
| Capital Expenditures | -$5M | -$4M | -$14M | -$534K | -$148K |
| Acquisitions (Net) | $0 | $4M | $0 | $9K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $4M | $13M | $0 | $0 |
| Other Investing | $220K | $284K | $261K | $261K | $261K |
| Investing Cash Flow | -$5M | $4M | -$1M | -$264K | $113K |
| — Financing Activities — | |||||
| Net Debt Issuance | $15M | -$1M | -$443K | -$16M | $14M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$4M | -$3M | -$4M | -$3M | -$4M |
| Financing Cash Flow | $11M | $9M | $2M | $7M | $10M |
| Net Change in Cash | $1M | $6M | -$5M | -$8M | -$319K |
| Cash End of Period | $10M | $16M | $11M | $3M | $3M |
| Free Cash Flow | -$10M | -$11M | -$20M | -$15M | -$11M |